Metraipolis › archive › dc_684ec6f2fa7b

Inducible CRISPR/Cas systems in precision oncology: Current applications and future perspectives — Europe PMC PMID:42298891

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42298891
DOI: 10.1002/ctm2.70720
License (as archived): solo-consultazione
Archived: 2026-10-31T23:03:19.722Z
SHA-256 of the archived text: af054980539297108fb5ed23908426ff7ebb3066446da0d601a9a22ee99e1310
Stable URL of this page: https://metraipolis.com/documento/dc_684ec6f2fa7b

How to cite

Inducible CRISPR/Cas systems in precision oncology: Current applications and future perspectives — Europe PMC PMID:42298891 — Europe PMC (en), https://europepmc.org/article/MED/42298891 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_684ec6f2fa7b (Metraipolis archive dc_684ec6f2fa7b, sha256 af054980539297108fb5ed23908426ff7ebb3066446da0d601a9a22ee99e1310)

BibTeX

@misc{dc684ec6f2fa7b,
  title = {Inducible CRISPR/Cas systems in precision oncology: Current applications and future perspectives — Europe PMC PMID:42298891},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42298891},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_684ec6f2fa7b; sha256 af054980539297108fb5ed23908426ff7ebb3066446da0d601a9a22ee99e1310},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42298891. Agents can read the archived copy with the MCP tool read_document.